EEG Abnormalities and Outcome in First-Episode Psychosis

Canadian Journal of Psychiatry

Volumn 48, Issue 11, 2003, Pages 722-726

  Manchanda, Rahul ^a   Malla, Ashok ^b,c   Harricharan, Rajendra ^a   Cortese, Leonardo ^a   Takhar, Jatinder ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

EEG; First episode psychosis; Outcome; Prognosis

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN DYSFUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EEG ABNORMALITY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; PSYCHOSIS; REMISSION; SCORING SYSTEM; SYMPTOM;

EID: 1042263793     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304801103     Document Type: Article

References (15)

1. Moller HJ, Von Zerssen D. Course and outcome of schizophrenia. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. Oxford: Blackwell Science Ltd; 1995. p 106-27.
2. Van Os J, Fahy A, Jones P, Harvey I, Sham P, Lewis S. Psychopathological syndromes in the functional psychosis: associations with course and outcome. Psychol Med 1996;26:203-8.
3. Czobor P, Volavka J. Pretreatment EEG predicts short-term response to haloperidol treatment. Biol Psychiatry 1991;30:927-42.
4. Small JG, Small IF. Re-evaluation of clinical EEG findings in schizophrenia. Dis Nervous System 1965;6:345-49.
5. Merlo MCG, Kleinlogel H, Koukkou M. Differences in the EEG profiles of early and late responders to antipsychotic treatment in first episode drug-naive psychotic patients. Schizophr Res 1998;30:221-8.
6. Mayo Clinic. Clinical examinations in neurology. Ch. 15. Rochester (MN): Mayo Clinic and Mayo Foundation for Medical Education and Research; 1991.
7. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders. Washington (DC): American Psychiatric Press; 1978.
8. Andreasen NC. Scale for assessment of positive symptoms (SAPS). Iowa City: University of Iowa College of Medicine; 1984.
9. Andreasen NC. Scale for assessment of negative symptoms (SANS). Iowa City: University of Iowa College of Medicine; 1983.
10. Malla AK, Norman RMG, Manchanda R, Ahmed R, Scholten D, Harricharan R, and others. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002;54:231-42.
11. Treves IA, Neufeld MY. EEG abnormalities in clozapine-treated schizophrenic patients. Eur Neuropsychopharmacol 1996;6:8:93-4.
12. Pillay SS, Stoll AL, Weiss MK, Tohen M, Zarate CA, Banov MD, and others. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiatry 1996;8:1-5.
13. Knott V, Labelle A, Jones B, Mahoney C. EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia. Clin Electroencephalogr 2000;31:3:145-52.
14. Weinberger DR, McClure RK, Neurotoxicity, neuroplasticity and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry 2002;49:553-8.
15. Pantelis C, Velakoulls D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, and others. Neuroanatomical abnormalities before and after onset of psychosis: a cross sectional and longitudinal MRI comparison. Lancet 2003;361:281-7.